Executive Director, Oncology Marketing, New Asset/ Alliance

Job Description

Our U.S. Oncology business is a growing and dynamic part of our company. We are currently seeking qualified candidates for the role of Executive Director, U.S. Oncology Marketing, New Asset/ Alliance. This alliance is focused on the commercialization of a novel individualized neoantigen therapy, currently in Phase III clinical development in multiple tumor types.

We are seeking an experienced and strategic leader to lead the U.S. Oncology Marketing Team and to serve as the U.S. representative to the alliance commercialization committee. This role is responsible for leading marketing and cross-functional teams within our company, with support from Alliance company, to set the vision, objectives, priorities, and tactical plans for successful commercialization (pre-launch, launch, and in-line), and for partnering with all support and execution teams in U.S. Oncology for implementation of the alliance agreed to Commercialization Plan. This position requires strong marketing and commercial leadership, the ability to manage multiple stakeholders, and a good understanding of P&L management.

This position will be based in Upper Gwynedd, PA and will report to the Associate Vice President, U.S. Oncology Marketing, Skin and GI/MSI-H Cancers.

The commercial planning and marketing pf V940 is unlike any other product on the market at this time. V940 is being commercialized by our company in partnership with Alliance company through a co-promotional arrangement, and thus carrying the nuances of an alliance as well as the unique product specific requirements. V940 is a product where the manufacturing process is the product, and each patient will receive a unique, individualized version of the therapy.

The marketing strategy and plans of V940 must account for an end-to-end seamless customer journey beginning with appropriate patient identification and acquisition of a patient tumor and blood sample, genetic sequencing of the samples, customized manufacturing of the individualized therapy and subsequent delivery back to the health care provider for administration to the patient. Developing and implementing the steps to enable this journey to flow optimally will require an extraordinary level of integrated planning and execution.

V940 is expected to have an initial launch in melanoma, and is being investigated for future indications in NSCLC, CSCC, RCC, and UC.

Desired skills and experiences the successful candidate will need:

• Strong marketing and commercial leadership experience with a good understanding of P&L management
• Ability to work in "white space" and successfully shape new approaches with cross-functional teams
• Experience managing an alliance or ability to come up to speed quickly with leading in an alliance structure
• Experience in developing commercialization strategies for cell therapies or similar medicines involving complex logistics and patient-specific manufacturing and distribution
• Ability to manage effectively in multi-layered leadership structures and to lead across complex cross-functional teams
• Strong balance of strategic thinking and execution
• High emotional intelligence and interpersonal skills, including grace under pressure and adaptability to other organizational cultures and ways of working
• Experience in building and nurturing large high-performing teams and practicing situational leadership
• Ability to navigate and drive change in the business and teams
• Strong background in executing and succeeding in competitive settings
• Experience with lifecycle management strategies and resourcing dynamics
• Experience in marketing forecasting for oncology products, including market size, class, and brand shares for various indications, competitors, and market events
• Understanding of the role of precision medicine in oncology, including testing and genetic sequencing processes
• Budget management and optimization of resources to maximize return on investment and channel mix.
• Lead and coordinate all marketing activities for new product (V940) in collaboration with alliance partner
• Lead integrated launch planning activities across broad set of cross-functional areas including global marketing, OCAR, IAM, supply chain and distribution, precision medicine, COLT, legal and compliance.
• Serve as primary internal decision point on commercialization choices
• Ensure appropriate implementation of Co-Promotion Agreement (CPA) with Alliance company
• Lead US forecasting for V940 in partnership with global marketing, finance, and global forecasting
• Present updates to senior leadership and responses for IR as needed
• Build marketing team for new asset with multiple indications in Phase III clinical trials.

Education Minimum Requirements:

• Bachelor's degree required
• Master's degree preferred

Required Experience and Skills:

• Minimum of 10 years pharmaceutical business experience, including marketing, people management in marketing and customer facing team(s),
• Demonstrated leadership in areas of significant business responsibility (revenue, strategy, etc.)
• Proficient understanding of oncology market
• Experience leading and prioritizing in complex, fast-paced environment
• Strong collaboration skills
• Excellent communication skills including ability to present clearly to executive level audiences
• Strong business and financial acumen
• Strong compliance IQ

Travel:

• Requires approximately 25% travel, including some weekends.

NOTICE FOR INTERNAL APPLICANTS

In accordance with Managers' Policy - Job Posting and Employee Placement, all employees subject to this policy are required to have a minimum of twelve (12) months of service in current position prior to applying for open positions.

If you have been offered a separation benefits package, but have not yet reached your separation date and are offered a position within the salary and geographical parameters as set forth in the Summary Plan Description (SPD) of your separation package, then you are no longer eligible for your separation benefits package. To discuss in more detail, please contact your HRBP or Talent Acquisition Advisor.

Employees working in roles that the Company determines require routine collaboration with external stakeholders, such as customer-facing commercial, or research-based roles, will be expected to comply not only with Company policy but also with policies established by such external stakeholders (for example, a requirement to be vaccinated against COVID-19 in order to access a facility or meet with stakeholders). Please understand that, as permitted by applicable law, if you have not been vaccinated against COVID-19 and an essential function of your job is to call on external stakeholders who require vaccination to enter their premises or engage in face-to-face meetings, then your employment may pose an undue burden to business operations, in which case you may not be offered employment, or your employment could be terminated. Please also note that, where permitted by applicable law, the Company reserves the right to require COVID-19 vaccinations for positions, such as in Global Employee Health, where the Company determines in its discretion that the nature of the role presents an increased risk of disease transmission.

Current Employees apply HERE

Current Contingent Workers apply HERE

US and Puerto Rico Residents Only:

Our company is committed to inclusion, ensuring that candidates can engage in a hiring process that exhibits their true capabilities. Please click here if you need an accommodation during the application or hiring process.

We are an Equal Opportunity Employer, committed to fostering an inclusive and diverse workplace. All qualified applicants will receive consideration for employment without regard to race, color, age, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status, or other applicable legally protected characteristics. For more information about personal rights under the U.S. Equal Opportunity Employment laws, visit:

EEOC Know Your Rights

EEOC GINA Supplement​

Pay Transparency Nondiscrimination

We are proud to be a company that embraces the value of bringing diverse, talented, and committed people together. The fastest way to breakthrough innovation is when diverse ideas come together in an inclusive environment. We encourage our colleagues to respectfully challenge one another's thinking and approach problems collectively.

Learn more about your rights, including under California, Colorado and other US State Acts

U.S. Hybrid Work Model

Effective September 5, 2023, employees in office-based positions in the U.S. will be working a Hybrid work consisting of three total days on-site per week, generally Tuesday, Wednesday and either Monday or Thursday, although the specific days may vary by site or organization, with Friday designated as a remote-working day, unless business critical tasks require an on-site presence. This Hybrid work model does not apply to, and daily in-person attendance is required for, field-based positions; facility-based, manufacturing-based, or research-based positions where the work to be performed is located at a Company site; positions covered by a collective-bargaining agreement (unless the agreement provides for hybrid work); or any other position for which the Company has determined the job requirements cannot be reasonably met working remotely. Please note, this Hybrid work model guidance also does not apply to roles that have been designated as "remote".

Search Firm Representatives Please Read Carefully
Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.

Employee Status:

Relocation:

VISA Sponsorship:

Travel Requirements:

Flexible Work Arrangements:

Shift:

Valid Driving License:

Hazardous Material(s):

Job Posting End Date:

*A job posting is effective until 11:59:59PM on the day BEFORE the listed job posting end date. Please ensure you apply to a job posting no later than the day BEFORE the job posting end date.

Job Posting End Date:08/15/2024

A job posting is effective until 11:59:59PM on the day BEFORE the listed job posting end date. Please ensure you apply to a job posting no later than the day BEFORE the job posting end date.

Requisition ID:R307064